Search This Blog

Friday, November 8, 2019

Fibrogen gains nearly 10% on positive test results

The Roxadustat Phase III program pooled analyses showed positive efficacy and no increased cardiovascular risk in patients with anaemia from chronic kidney disease.
Source: Press Release
FGEN +9.5%
Posted by at

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.

Subscribe to: Post Comments (Atom)